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Abstract
Background: A genetic liability for anxiety-related personality traits in healthy subjects has been associated with
the functional serotonin transporter promoter polymorphism (5-HTTLPR), although the data are somewhat
conflicting. Moreover, only one study has investigated the functional significance of the 5-HTTLPR/rs25531
haplotypes in relation to anxiety traits in healthy subjects. We tested whether the 5-HTTLPR polymorphism and the
5-HTTLPR/rs25531 haplotypes are linked to Harm Avoidance (HA) using an association study (STUDY I) and a meta-
analytic approach (STUDY II).
Methods: STUDY I: A total of 287 unrelated Italian volunteers were screened for DSM-IV Axis I disorders and
genotyped for the 5-HTTLPR and rs25531 (A/G) polymorphisms. Different functional haplotype combinations were
also analyzed. STUDY II: A total of 44 studies were chosen for a meta-analysis of the putative association between
5-HTTLPR and anxiety-related personality traits.
Results: STUDY I: In the whole sample of 287 volunteers, we found that the SS genotype and S’S’ haplotypes were
associated with higher scores on HA. However, because the screening assessed by Mini-International Neuropsychiatric
Interview (M.I.N.I.) showed the presence of 55 volunteers affected by depression or anxiety disorders, we analyzed the
two groups ("disordered” and “healthy”) separately. The data obtained did indeed confirm that in the “healthy” group,
the significant effects of the SS genotype and S’S’ haplotypes were lost, but they remained in the “disordered” group.
STUDY II: The results of the 5-HTTLPR meta-analysis with anxiety-related traits in the whole sample confirmed the
association of the SS genotype with higher anxiety-related traits scores in Caucasoids; however, when we analyzed only
those studies that used structured psychiatric screening, no association was found.
Conclusions: This study demonstrates the relevance to perform analyses on personality traits only in DSM-IV axis I
disorder-free subjects. Furthermore, we did not find an association between functional serotonin transporter gene
polymorphisms and anxiety traits in healthy subjects screened through a structured psychiatric interview.
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Background
Personality traits can be defined as individual qualities
or characteristics that influence cognitions, emotions,
and behaviors and lead to adaptive or maladaptive
responses. Human personality is a multidimensional
structure that is affected by both environmental and
genetic factors. According to the literature, individual
variation of the heritable component is estimated to
account for 30-40% of the variance in personality traits
[1]. To date, the most frequently studied candidate gene
for personality traits has been the functional polymorph-
ism 5-HTTLPR in the promoter region of the SLC6A4
gene, which encodes the serotonin transporter. This
polymorphism results in a short (S) and a long (L)
variant [2,3].
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Functional studies of the activity of the SLC6A4 pro-
moter in transfected cell lines, postmortem human
brains, and lymphoblasts have confirmed that the L
allele is associated with higher levels of transcriptional
activity and influences the rate of serotonin uptake
more than the S variant [4]. According to recent find-
ings, the S allele is associated with a less favorable
response/resistance to pharmacological treatment [5-8]
but also with central stress regulation [9-11].
Recently it has been critically discussed that the analysis
of 5-HTTLPR is incomplete, because other polymorph-
isms have been found in the proximity of the Ins/Del
locus, such as rs25531, rs25532, rs2020933, and a 17-bp
variable tandem repeat in the second intron (STin2)
[4,12,13]. In particular, rs25531, the polymorphism nearest
5-HTTLPR, results in an A to G substitution and has been
shown to modulate the effect of 5-HTTLPR on transcrip-
tional efficacy. Our recent work [8] reported evidence that
the rs25531 polymorphism is located immediately outside
of the 5-HTTLPR segment, resulting in the status of
5-HTTLPR and rs25531 as two independent polymorph-
isms. It has been reported that the G allele of rs25531 is in
phase with the 5-HTTLPR long allele and mitigates tran-
scriptional efficacy more than does the 5-HTTLPR short
allele. Therefore, the modulation of 5-HTTLPR by
rs25531 results in haplotypes with a high (LA) or low (LG,
SA or SG) transcriptional efficacy [4,14].
The inventories mostly used in biological studies of per-
sonality are the NEO-Personality Inventory [15] and the
Temperament and Character Inventory (TCI) [16].
Although NEO and TCI have relevant differences, they
appear similar when evaluating anxiety traits such as Neu-
roticism (N) and Harm Avoidance (HA). Several studies
have shown that N is highly related to HA [17,18], but there
is evidence that N and HA may not be equivalent [19].
Since the first paper of Lesch [3] was published, a large
number of studies have sought evidence of an association
between the 5-HTTLPR polymorphism and anxiety-
related personality traits. Despite these investigations, the
strength and nature of any association is still uncertain.
Controvertible results were obtained using both the TCI
and NEO scales. In addition, five meta-analyses [20-24]
provided conflicting results. In 2003, Munafò [20] reported
an association between the 5-HTTLPR polymorphism and
avoidance traits, but this effect was no longer being signifi-
cant when data from studies reporting allele frequencies
not in Hardy-Weinberg equilibrium (HWE) and unpub-
lished data were excluded. Two successive meta-analyses
[23,24] found an association between N and 5-HTTLPR,
although no link with HA was observed. However, oppos-
ing data were reported in a different meta-analysis in 2005
[21]. Munafò et al. [21] concluded that the effect, if pre-
sent, is small. More recently, the same authors [22] pre-
sented a more complete meta-analysis, which evidenced
no association of 5-HTTLPR with HA and a significant
association with N; however, the association was lost due
to high between-study heterogeneity in analyses conducted
using the random effects model.
It is important to emphasize that these contrasting
results may be explained by the inclusion of studies that
recruited participants from psychiatric populations. Both
Schinka and Sen’s meta-analyses [23,24] included data
from healthy and patients whereas the different Munafò’s
meta-analyses [20-22] explicitly excluded studies that
recruited from psychiatric populations and, when both
psychiatric and control samples were recruited, data
from healthy controls only were included. Indeed, the
personality traits of pathological people could be con-
founding factors. It has long been known that depression
and anxiety disorders are associated with higher scores
for anxiety-related traits [25-28]. In addition, a higher
frequency of the S allele was observed in depressed and
anxious disorders patients [29]. Another relevant bias
could be the inclusion of data from presumably healthy
subjects without any psychological screening to exclude
any DSM-IV axis I psychiatric disorders.
On the basis of these conflicting evidences we per-
formed the following analyses: 1) STUDY I: an associa-
tion study between the 5-HTTLPR and rs25531 and the
relative estimated/phased haplotypes with anxiety per-
sonality traits measured using the self-rated TCI scale.
The analyses were carried out in the whole sample of
controls as well as in subjects without any DSM-IV axis
I disorders screened by structured interviews; 2) STUDY
II: meta-analyses of 5-HTTLPR and HA or N in con-
trols and in screened samples.
STUDY 1: A new association study of 5-HTTLPR and
5-HTTLPR/rs25531 with HA
Methods
Participants
A total of 287 unrelated volunteers (age: 50.05 ± 15.94
years [mean ± SD]; range: 22 to 87 years; 117 males and
170 females) were recruited through a variety of sources,
such as universities, newspaper advertisements, and
elderly associations. The study protocol was approved by
the Ethics Committee of Fatebenefratelli Hospital (San
Giovanni di Dio, Brescia, Italy), and written informed
consent was obtained from all the subjects. The subjects
were screened for DSM-IV Axis I disorders through the
Mini-International Neuropsychiatric Interview (M.I.N.I.)
[30] and screened for any history of drug or alcohol
abuse or dependence by expert psychologists. Personality
traits were assessed by the Italian version of TCI, a 240-
item true-false self-report questionnaire [31]. Subjects
who scored less than 27/30 on the Mini-Mental State
Examination (M.M.S.E.) [32] were excluded from the
study to avoid biases in the completion of the TCI.
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Genotyping analyses of 5-HTTLPR and rs25531
Isolation of DNA, genotyping of 5-HTTLPR and
rs25531, as well as the classification of estimated phased
haplotypes (SASA, SGSG, LGSA, and LGLG as S’S’; LA SA
and LALG as L’S’; and LALA as L’L’) were described in a
study by Bonvicini [8]. We did not detect the LGLG or
SGSG haplotypes in the genotyping analyses.
Statistical analysis
The association between TCI scores and 5-HTTLPR or
5-HTTLPR/rs25531 was analyzed by analysis of var-
iance, using the HA score as the dependent variable,
genotypes and sex as independent variables, and age as
a covariate (ANCOVA). The p-values have been cor-
rected for multiple comparisons. All analyses were con-
ducted using SPSS statistical software version 12.0
(SPSS Inc., Chicago, IL).
The association study showed a power > 80% by using
the Quanto program version 1.2.4 with the following
parameters: 5-HTTLPR S and S’S’ minor allele frequen-
cies (MAFs) of 15% and 21%, respectively, in a popula-
tion of European origin; p ≤ 0.05; OR ≥ 1.6; log additive
mode of inheritance; and population risk ≥ 10%.
Results
In the whole sample of 287 volunteers, the minor S allele
frequency of the 5-HTTLPR polymorphism was 0.39; the
genotype frequencies and HA (mean score +/- SD) of LL,
LS, and SS were 0.37 (43.42 +/- 17.14), 0.48 (42.55 +/-
17.96) and 0.15 (48.57 +/- 20.18), respectively (Table 1).
The genotype distributions were in HWE (c2 = 0.05; p =
0.82). The results indicated a trend toward an association
between 5-HTTLPR and anxiety-related scale for geno-
types (p = 0.06), and a significant effect was found when
we considered the L allele as dominant (p = 0.02). Con-
cerning the analysis of the 5-HTTLPR/rs25531 the
ANCOVA results showed an effect using a dominant L
model (L’L’ + L’S’ vs. S’S’ p = 0.05, Table 1).
Based on the assessment performed using M.I.N.I., the
sample consisted of 229 (80%) subjects without lifetime
DSM-IV Axis I disorders (the “healthy” group) and 58
subjects (20%) with these disorders (the “disordered”
group). In the “disordered” group, 38 subjects had MDD,
2 had Panic Disorder, 22 had Generalized Anxiety Disor-
der, 6 had Dysthymia, 1 had Bipolar Disorder, 1 experi-
enced alcohol abuse and 1 experienced substance abuse
(the total number exceeds the number of subjects due to
the presence of comorbidity). Because the literature has
largely shown that people affected by unipolar major
depression and anxiety disorders present homogeneous
patterns of personality traits compared to other subjects
[25-28,33-36], the 55 participants with depression and/or
anxiety lifetime diagnosis were regrouped. The three
subjects affected by Bipolar Disorder, experienced alcohol
and substance abuse were consequently excluded.
Thus, to evaluate whether the results from the partici-
pants excluded by M.I.N.I. had influenced the previous
analyses, we performed ANCOVA using the HA score
as the dependent variable, groups ("healthy” N = 229,
“disordered” N = 55), genotypes, and sex as independent
variables, and age as a covariate for both 5-HTTLPR
and estimated/phased haplotypes. The results indicated
that, the disordered group showed significantly higher
HA scores than healthy subjects (F = 46.72, p < 0.0001).
No association was found between 5-HTTLPR poly-
morphism and anxiety traits (F = 1.34, p = 0.26),
whereas a significant interaction was observed between
the 5-HTTLPR genotype and groups (F = 4.52, p =
0.03). The same pattern was obtained when the SS gen-
otype was compared to allele L carriers (F = 4.41, p =
0.04). Concerning the 5-HTTLPR/rs25531, a significant
interaction was detected with the dominant L model
(L’L’ + L’S’ vs. S’S’; p = 0.02). In all analyses, no signifi-
cant gender effect or interaction was obtained.
In the sample of subjects with no DSM-IV axis I disor-
ders (healthy group), we performed an ANCOVA analysis
to test the possible association between polymorphisms
and HA. There was no significant association between HA
and either the 5-HTTLPR or the 5-HTTLPR/rs25531 hap-
lotypes (Table 1). Despite its small size, the disordered
group revealed an association between HA and SS or S’S’
homozygosity (p = 0.05 and p = 0.03, respectively).
STUDY 2: Meta-analyses of 5-HTTLPR with anxiety
traits
Methods
Literature search
To identify eligible studies for the meta-analysis, we per-
formed a search through PubMed (at the National
Library of Medicine) for all the available studies of the
association between the serotonin transporter and anxi-
ety personality traits conducted in healthy adults, using
the following search terms: serotonin transporter poly-
morphism, serotonin transporter gene, 5-HTTLPR, Neu-
roticism, Harm Avoidance, anxiety, and personality.
Once articles had been collected, bibliographies were
manually searched for additional eligible studies.
Inclusion criteria
All association studies that have measured anxiety traits
using any version of NEO (NEO-PI, NEO-PI-R, or
NEO-FFI) or the TCI (or TPQ) in male and/or female
participants of any ethnic origin were included. Only
data from controls were included from studies in which
psychiatric patients and control data were compared.
Data that appeared in more than one published study
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were included only once in the analyses. Papers not
written in English [37] were excluded.
Data extraction
We recorded the number of participants, the mean of N
and/or HA trait scores, and the standard deviation for
each of the three genotype groups (LL, LS, SS) in each
study included in our analysis. Furthermore, we
extracted data regarding the male/female ratio, the
mean age, the ethnic compositions of the sample, and
the structured clinical interview used for screening.
Genotype frequencies were used to calculate the HWE
(program http://www.genemapping.cn). In cases where
all or part of this information was not available in the
publication, the authors were contacted by email.
Statistical analyses
The Review Manager was used to analyze data (RevMan
Version 5.0.16; Copenhagen, The Nordic Cochrane Cen-
tre, The Cochrane Collaboration, 2008).
Firstly, data were analyzed with the fixed effects
model in order to combine individual study effect sizes
(Cohen’s ds) using inverse variance methods to gener-
ate a summary d and 95% confidence interval (CI). We
analyzed a possible association by both comparing LL
genotype versus carriers of the S allele and SS geno-
type versus carriers of the L allele. The significance of
the pooled effect sizes was determined by the Z-test
and the between-study heterogeneity was assessed
using a c2 test of goodness of fit and I2 statistic [38].
The significant p value was set at 0.05. In a fixed
effects model, the fundamental assumption is that a
single true effect size underlies all study results and
that observed estimates vary only as a function of
chance. The error term in a fixed effects model repre-
sents only within-study variation, and between-study
variation is ignored. Where the results showed a signif-
icant effect in the presence of significant between-
study heterogeneity, a random effects model was uti-
lized, with ds pooled using the DerSimonian and Laird
Table 1 HA scores (Mean ± Standard Deviation) of all participants, including screened healthy subjects and people
excluded for depression and anxiety disorders, stratified according to the 5-HTTLPR and the 5-HTTLPR/rs25531
estimated/phased haplotypes
All subjects (287) Healthy subjects (229) Disordered subjects b (55)
Genotype 5-
HTTLPR
N (freq.
%)
HA (mean ±
SD)
p
(ANCOVA)a
N (freq.
%)
HA (mean ±
SD)
p
(ANCOVA)a
N (freq.
%)
HA (mean ±
SD)
p
(ANCOVA)a
LL 107 (0.37) 43.42 ± 17.14 F = 2.84 93 (0.41) 41.63 ± 15.66 F = 0.34 13 (0.24) 57.14 ± 21.73 F = 1.85
LS 138 (0.48) 42.55 ± 17.96 p = 0.06 109 (0.48) 39.08 ± 16.72 p = 0.71 27 (0.49) 56.19 ± 16.88 p = 0.17
SS 42 (0.15) 48.57 ± 20.18 27 (0.11) 37.25 ± 12.11 15 (0.27) 68.95 ± 15.11
Carriers
Carriers L 245 (0.85) 42.93 ± 17.57 F = 5.73 202 (0.89) 40.25 ± 16.25 F = 0.18 40 (0.73) 56.50 ± 18.32 F = 3.86
vs SS p = 0.02 p = 0.67 p = 0.05
Carriers S 180 (0.63) 43.95 ± 18.62 F = 0.37 136 (0.59) 38.72 ± 15.89 F = 0.70 42 (0.76) 60.75 ± 17.24 F = 0.60
vs LL p = 0.54 p = 0.40 p = 0.44
Phased Haplotype frequencies
LALA 93 (0.32) 42.27 ± 16.60 F = 2.00 82 (0.36) 40.70 ± 14.97 F = 0.59 10 (0.18) 56.29 ± 23.41 F = 1.14
LALG 14 (0.05) 51.02 ± 19.28 p = 0.09 11 (0.05) 48.57 ± 19.55 p = 0.67 3 (0.05) 60.00 ± 18.73 p = 0.35
LASA 120 (0.42) 42.41 ± 17.58 94 (0.41) 38.85 ± 16.14 25 (0.46) 55.20 ± 17.16
LGSA 18 (0.06) 43.49 ± 20.82 15 (0.07) 40.57 ± 20.58 2 (0.04) 68.57 ± 4.04
SASA 42 (0.15) 48.57 ± 20.18 27 (0.11) 37.25 ± 12.11 15 (0.27) 68.95 ± 15.11
Clustered Phased Haplotype frequencies
L’L’ 93 (0.32) 42.27 ± 16.60 F = 2.12 82 (0.36) 40.70 ± 14.97 F = 0.04 10 (0.18) 56.29 ± 23.41 F = 2.50
L’S’ 134 (0.47) 43.30 ± 17.88 p = 0.12 105 (0.46) 39.86 ± 16.69 p = 0.96 28 (0.51) 55.71 ± 17.03 p = 0.09
S’S’ 60 (0.21) 47.05 ± 20.34 42 (0.18) 38.43 ± 15.50 17 (0.31) 68.91 ± 14.17
Carriers of Phased haplotypes
(L’L’ + L’S’) 227 (0.79) 47.05 ± 20.34 F = 3.92 187 (0.82) 38.43 ± 15.50 F = 0.08 38 (0.69) 68.91 ± 14.17 F = 5.15
vs (S’S’) p = 0.05 p = 0.77 p = 0.03
(L’S’ + S’S’) 194 (0.68) 44.46 ± 18.70 F = 1.47 147 (0.64) 39.45 ± 16.32 F = 0.04 45 (0.82) 60.70 ± 17.11 F = 0.81
vs L’L’ p = 0.23 p = 0.85 p = 0.37
The ANCOVA results for the genotypes, clustered genotype, and carriers are included.
a HA score as the dependent variable, genotype or clustered genotype and sex as independent variables, and age as a covariate.
b Disordered group consisted of subjects with depression and anxiety disorders.
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methods [39]. In contrast, a random effects model
assumes that each study estimates different, yet related,
true effects and that the distribution of the various
effects is normally distributed around a mean effect
size value. This model takes both within- and between-
study variation into account. When there is little het-
erogeneity, both models yield essentially identical
results. When heterogeneity is extensive, however, the
analyses will yield different estimates of the mean
effect size, and the confidence intervals around the
estimates will be different sizes. When there is hetero-
geneity across studies, the random effects model yields
wider confidence intervals than the fixed effects model
and is thus usually more conservative.
Results
A total of 50 studies [3,22,40-88] met our inclusion cri-
teria; their features are shown in Table 2. Six studies
were excluded from our analyses for significant deviation
from HWE (p ≤ 0.05) [46,52,60,65,74,81], and one was
excluded for excessive ethnic heterogeneity [56]. Further-
more, nine other studies [50,62,63,67,68,71,76,78,86]
were not included because the data regarding anxiety
traits for each genotype and/or the data to test HWE
were insufficient, and we were unable to obtain this kind
of information from the authors.
Therefore, the meta-analysis used the results of 35
studies, including 7 [41,49,55,59,69,84,85] that reported
data for both inventories, 1 [83] that generated data on
NEO on 2 different independent samples, and the data
of present work; in total, 44 samples were available for
analysis.
Because of ethnic differences in the 5-HTTLPR genotype
distribution, the studies on Asian and Caucasoid popula-
tions were independently analyzed. When we conducted a
comparison analysis between the LL genotype and S allele
carriers in the Caucasoid population (Figure 1), no associa-
tion was observed between 5-HTTLPR and HA (p = 0.94),
Table 2 Characteristics of association studies eligible for inclusion
Study Year Inventorya N % Male Mean Age Ethnicity HW equilibrium HW c2 HW p Exclusion
Lesch 1996 NEO 505 92 37.6 94% Caucasian YES 0.01 0.93
Ebstein 1997 TCI 121 55 29.7 74% Caucasian YES 1.14 0.29
Nakamura 1997 Both 186 0 19.6 Asian YES 1.15 0.28
Mazzanti 1998 TCI 215 85 35.5 Caucasian YES 0.01 0.98
Ricketts 1998 TCI 37 nd nd Caucasian YES 2.10 0.15
Flory 1999 NEO 225 50 45.7 84% Caucasian YES 0.16 0.69
Hamer 1999 TCI 634 43 31.3 79% Caucasian NO 3.85 0.04 Excludedb
Katsuragi 1999 TCI 101 61 25.0 Asian YES 0.02 0.88
Kumakiri 1999 Both 144 42 24.4 Asian YES 1.28 0.26
Benjamin 2000 TCI 455 40 nd Caucasian N/A Excludedd
Comings 2000 TCI 81 100 32.9 Caucasian YES 0.10 0.75
Du 2000 NEO 186 41 36.3 Caucasian YES 0.77 0.38
Greenberg 2000 NEO 397 16 28.6 Caucasian NO 4.75 0.03 Excludedb
Herbst 2000 TCI 425 51 43.8 67% Caucasian YES 0.79 0.38
Hu 2000 NEO 759 62 29.2 81% Caucasian YES 1.57 0.21
Osher 2000 Both 148 34 30.7 Caucasian YES 0.11 0.75
Schmidt 2000 NEO 72 48 27.0 54% Caucasian YES 0.06 0.80 Excludedc
Samochowiec 2001 TCI 126 30 23.8 Caucasian YES 1.26 0.26
Cohen 2002 TCI 559 0 nd Caucasian NO 9.51 0.01 Excludedb
Tsai 2002 TCI 192 49 29.3 Asian YES 2.30 0.13
Brummett 2003 NEO 99 32 70.3 87% Caucasian YES 0.70 0.40
Umekage 2003 NEO 244 8 37.7 Asian YES 2.08 0.15
Ham 2004 TCI 146 32 31.9 Asian YES 0.01 0.98
Jacob 2004 Both 281 25 22.4 Caucasian YES 0.59 0.44
Lang 2004 NEO 228 50 38.6 Caucasian YES 1.14 0.29
Park 2004 TCI 100 0 48.3 Asian YES 2.41 0.12 Excludedd
Samochowiec 2004 Both 100 47 41.0 Caucasian YES 0.04 0.85
Szekely 2004 TCI 151 43 22.2 Caucasian YES 0.59 0.44
Thierry 2004 TCI 76 0 32.8 Caucasian YES 0.01 0.96 Excludedd
Sen 2004 NEO 415 33 43.8 Caucasian NO 3.76 0.05 Excludedb
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and no evidence of between-study heterogeneity was
apparent. A significant association with N (p < 0.01), indi-
cating a higher anxiety trait score, and evidence of highly
significant between-study heterogeneity (p < 0.0001, I2 =
74%) were found in the S allele carriers group. When the
analysis was run again using the random effects method,
the significant effect just described was no longer signifi-
cant. No evidence for an association between the 5-
HTTLPR genotype and N (p = 0.09) as well as no overall
effect (p = 0.11) was shown.
When we tested the L allele carriers versus the SS
genotype in the same ethnic population (Figure 2), no
association was found between 5-HTTLPR and HA or
N, and there was no evidence of between-study hetero-
geneity. Instead, a significant overall effect was obtained
(p = 0.03), and the two subgroups did not show signifi-
cant differences (c2 [1] = 0.01, p = 0.95, I2 = 0%).
In the Asian population, no association was observed
between the LL genotype and carriers of the S allele,
using either TCI (d = -0.01, 95% CI = -0.24, 0.22, Z =
0.10, p = 0.92) or NEO (d = -0.15, 95% CI = -0.54, 0.24,
Z = 0.75, p = 0.46). After clustering of the L allele
carriers versus the SS genotype, there was no significant
evidence of an association between 5-HTTLPR and
either HA or N (d = -0.06, 95% CI = -0.16, 0.04, Z =
1.13, p = 0.26; and d = -0.12, 95% CI = -0.29, 0.05, Z =
1.38, p = 0.17; respectively). We did not find between-
study heterogeneity in any groups.
Because of the bias inherent in a mix of healthy sub-
jects with depressed or anxious people, we carried out a
meta-analysis including only the studies with structured
psychiatric interview screening [42,43,59,66,73,75,88].
No significant result was found when we considered an
L dominant model (TCI: d = 0.00, 95% CI -0.12, 0.12, Z
= 0.01, p = 1.00; NEO: d = -0.02, 95% CI -0.22, 0.18, Z
= 0.19, p = 0.85; Overall effect p = 0.92) or a recessive
model (TCI: d = -0.10, 95% CI = -0.25, 0.04, Z = 1.40, p
= 0.16; NEO: d = -0.12, 95% CI = -0.39, 0.14, Z = 0.93,
p = 0.35; Overall effect p = 0.09).
Discussion
The present study demonstrates the relevance of
employing more stringent inclusion/exclusion criteria in
association studies on healthy subjects. Our results show
Table 2 Characteristics of association studies eligible for inclusion (Continued)
Bachner-Melman 2005 TCI 872 nd 21.4 N/A N/A Excludedc,d
Hariri 2005 TCI 92 49 30.5 Caucasian N/A Excludedd
Kim 2005 TCI 211 51 26.5 Asian YES 0.06 0.81 Excludedd
Kremer 2005 TCI 730 nd nd N/A N/A Excludedc,d
Dragan 2006 NEO 196 0 21.7 Caucasian YES 2.07 0.15
Lazagorta 2006 TCI 57 nd 45 Other YES 3.70 0.05 Excludedb,c
Monteleone 2006 TCI 94 0 nd Caucasian YES 2.37 0.12
Serretti 2006 TCI 132 nd nd Caucasian YES 0.02 0.90
Vorfelde 2006 Both 195 50 nd Caucasian YES 0.48 0.49
Hunnerkopf 2007 NEO 272 25 21.9 Caucasian N/A Excludedd
Joo 2007 TCI 158 44 23.8 Asian YES 0.13 0.72
Nilsson 2007 TCI 196 60 17 Caucasian YES 1.07 0.30
Schmitz 2007 Both 410 36 24 Caucasian YES 0.07 0.78
Stein 2008 NEO 247 31 18.8 61% Caucasian NO 3.88 0.05 Excludedb
Lee 2008 TCI 75 100 16.1 Asian YES 2.97 0.08 Excludedd
Kazantseva 2008 TCI 301 20 19.8 Caucasian YES 1.24 0.26
Suzuki 2008 TCI 575 51 28.7 Asian YES 0.14 0.71
Munafò 2009 TCI 3872 44 42 Caucasian YES 0.26 0.61
Gonda 2009 TCI 169 0 nd Caucasian YES 0.20 0.65
Terraccianoe 2009 NEO 3972 43 42.5 Caucasian YES 1.33 0.25
Terraccianof 2009 NEO 1182 52 57.3 71% Caucasian YES 0.87 0.35
Saiz 2010 TCI 404 50 40.5 Caucasian YES 0.76 0.38
Present Study TCI 229 45 49.2 Caucasian YES 0.33 0.56
HW = Hardy-Weinberg; HW c2 = Hardy-Weinberg chi square; HW p = Hardy-Weinberg p value; nd = not determined; N/A = not applicable.
a The term NEO referred to all versions (i.e. NEO-PI, NEO-PI-R, NEO-FFI); the term TCI referred to all versions (TPQ).
b Excluded because genotype frequencies showed deviation from Hardy-Weinberg equilibrium.
c Excluded due to the ethnic heterogeneity or lack of data about ethnic origin.
d Excluded because of unavailable data.
e Data referred to SardiNIA sample.
f Data referred to BLSA (Baltimore Longitudinal Study of Aging) sample.
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the influence of mistakes in the selection of subjects,
underscoring the importance of the use of a structured
psychiatric interview when people are enrolled as con-
trol subjects for this type of study. When we performed
analyses on the whole sample of 287 volunteers, effects
on the susceptibility to HA were found for both the SS
genotype and the S’S’ haplotypes. However, because the
screening performed by M.I.N.I. revealed the presence
of depression or anxiety disorders in 55 volunteers (the
“disordered” group), we verified the possible influence of
the variable “groups” ("healthy” and “disordered”) on the
genotypes. The results evidenced a significant interac-
tion between genotypes and groups (5-HTTLPR; p =
0.03 and 5-HTTLPR/rs25531 L’L’ + L’S’ vs. S’S’; p =
Figure 1 Meta-analysis of 5-HTTLPR LL versus carriers S allele. Meta-analysis of association studies of serotonin transporter gene and
anxiety-related personality traits measured by NEO and TCI in Caucasoid population. It was used fixed effects model testing the comparison
between LL genotype versus carriers S allele. Bars represent individual study 95% CI, with a central block proportional to study effect size, while
summary diamond bar represents the pooled effect size estimate and 95% CI.
Minelli et al. BMC Psychiatry 2011, 11:50
http://www.biomedcentral.com/1471-244X/11/50
Page 7 of 12
0.02); thus, we conducted the analyses separately for
these groups. The data confirmed that in the “healthy”
group, the effects of the SS genotype and the S’S’ haplo-
types were lost, but they remained in the “disordered”
group. In addition, we conducted a meta-analysis invol-
ving approximately 18,000 controls of Caucasoid and
Asian descent and considering anxiety traits measured
by TPQ/TCI or NEO. Similarly, an association was
observed between S allele in homozygosity and higher
scores for anxiety-related traits, but when we analyzed
only the studies that used structured psychiatric screen-
ing, no association was found.
Moreover, another important finding from both
STUDY I and STUDY II is the absence of a role of the
Figure 2 Meta-analysis of 5-HTTLPR SS versus carriers L allele. Meta-analysis of association studies of serotonin transporter gene and
anxiety-related personality traits measured by NEO and TCI in Caucasoid population. It was used fixed effects model testing the comparison
between carriers L allele versus SS genotype. Bars represent individual study 95% CI, with a central block proportional to study effect size, while
summary diamond bar represents the pooled effect size estimate and 95% CI.
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serotonin transporter gene in anxiety personality traits
in healthy subjects.
To date, five meta-analyses have been conducted on
the involvement of the functional 5-HTTLPR poly-
morphism with anxiety personality traits [20-24]. Schin-
ka’s and Sen’s meta-analyses [23,24] found a strong
association of 5-HTTLPR with N and no link to HA,
whereas Munafò [20-22] reported contrasting data; in
particular no strong effect was detected [20,22] and,
when present, it was small [21]. As discussed in the
2005 study by Munafò [21], the association found in
Schinka and Sen’s meta-analyses [23,24] may have been
biased by the inclusion of studies that recruited partici-
pants from psychiatric populations. However, there is
another bias that the Munafò meta-analyses [20-22] did
not take in consideration: the presence of studies in
which structured psychiatric screening was not per-
formed, producing a lack of information about the
patients’ lifetime history of psychiatric disorders. On this
basis, we tried to verify whether the absence of a psy-
chiatric screening interview might represent an impor-
tant confounding variable in studies regarding the
biological basis of personality traits in healthy popula-
tions. Indeed, STUDY I indicated an association
between the SS genotype and S’S’ haplotypes in 5-
HTTLPR/rs25531 and anxiety traits in the whole sample
of volunteers, but these effects were probably found due
to the presence of subjects with depression and anxiety
disorders. In fact, as reported in Table 1, these subjects
have higher scores for HA and a higher frequency of
homozygous SS or S’S’. More importantly, the results of
STUDY II lead to the same direction.
It is well known that anxiety traits are strongly linked to
depression and anxiety disorders [25-28,33-36,89] and
indeed, the premorbid depressive personality represents
an emotional vulnerability that increases the likelihood of
developing these disorders during stressful life events.
Furthermore, the literature supports the hypothesis that
5-HTTLPR S allele could be a risk factor for major depres-
sion/anxiety spectrum disorders [29]. Taking together the
two issues, our findings seem to be contradictory. How-
ever, recently it has been proposed the hypothesis about a
role of the SLC6A4 gene not directly in the MDD suscept-
ibility but rather in the some features of the pathology
such as the response/resistance to antidepressant treat-
ment [5-8], or the interaction with the stressful life events,
given the robust correlation between these events and risk
of developing depressive symptoms [9-11,90].
In our recent paper [8], we have supported the evi-
dence about the modulation of 5-HTTLPR by rs25531
showing that LG haplotype has lower transcriptional effi-
cacy as well as the S allele. Therefore, in STUDY I we
conducted association analyses for 5-HTTLPR/rs25531
to investigate the influence of rs25531. The results
showed the association with HA in the “disordered
group”. In light of these data, we speculate that the
genotyping of both the functional polymorphisms
(5-HTTLPR and rs25531) and the haplotypes analysis
should be taken into account in relation to anxiety-
related personality traits.
Finally, in STUDY II, because the S allele is much
more prevalent in Asians than in Caucasians [41,49,58],
suggesting that ethnic differences may be a confounding
factor in association studies of the 5-HTTLPR genotype,
we conducted separate analyses for both populations to
avoid biased conclusions. No significant association was
found between 5-HTTLPR and either N or HA.
Conclusions
This study supports the following conclusions: 1. A lack
of structured psychiatric screening of subjects may pro-
duce an important bias in genetic association studies on
personality traits using controls. The symptomatology of
depressive and anxiety disorders might interfere with
anxiety-related traits in possible associations with the
serotonin transporter and the higher frequency of the S
allele observed in depressed and anxiety disorder
patients; 2. The SLC6A4 gene is not involved in anxiety-
related traits measured by TCI and NEO in psychiatri-
cally healthy subjects.
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